FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR-Reference-Cited by-同舟云学术

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

Published:2011-03 Issue:7339 Volume:471 Page:523-526
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Bivona Trever G.,Hieronymus Haley,Parker Joel,Chang Kenneth,Taron Miquel,Rosell Rafael,Moonsamy Philicia,Dahlman Kimberly,Miller Vincent A.,Costa Carlota,Hannon Gregory,Sawyers Charles L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09870.pdf

Reference23 articles.

1. Haber, D. A. et al. Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors. Cold Spring Harb. Symp. Quant. Biol. 70, 419–426 (2005)

2. Miller, V. A. et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. J. Clin. Oncol. 26, 1472–1478 (2008)

3. Weinstein, I. B. & Joe, A. Oncogene addiction. Cancer Res. 68, 3077–3080 (2008)

4. Knight, Z. A., Lin, H. & Shokat, K. M. Targeting the cancer kinome through polypharmacology. Nature Rev. Cancer 10, 130–137 (2010)

5. Sos, M. L. et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 69, 3256–3261 (2009)

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of transcriptomic and proteomic expression between two non-small cell lung cancer subtypes;2024-09-10

2. Effect of PAWI-2 on pancreatic cancer stem cell tumors;Investigational New Drugs;2024-05-25

3. Thiostrepton suppresses triple-negative breast cancer through downregulating c-FLIP/SMAD2/3 signaling pathway;Journal of Asian Natural Products Research;2024-04-18

4. TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer;npj Precision Oncology;2024-03-02

5. TRAF2 inhibits senescence in hepatocellular carcinoma cells via regulating the ROMO1/ NAD+/SIRT3/SOD2 axis;Free Radical Biology and Medicine;2024-02